Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTAPAP

ACETAMINOPHEN; BUTALBITAL

Standard Dose
650MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTAPAP is listed in Drugs@FDA under application 089988 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL Form and strength TABLET;ORAL - 650MG;50MG Sponsor MIKART Submission history Latest submission status date: 2002-08-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTAPAP is listed in Drugs@FDA under application 089988 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL Form and strength TABLET;ORAL - 650MG;50MG Sponsor MIKART Submission history Latest submission status date: 2002-08-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BUTAPAP (ACETAMINOPHEN; BUTALBITAL) | Drug Monograph | MedicHelpline